Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Hour-by-Hour Action Plan for the CEO: First 24 Hours: Data Verification and Strategic Planning Hours 0–2: Confirm Findings with Internal Research Team Action: Convene an emergency meeting with the research team to validate the data. Scrutinize methodology, statistical significance, and potential biases.Read the full answer
As CEO, I would not wait six months and I would not let the board delay disclosure while patients remain exposed to an unreported serious risk. I would treat this as a patient-safety, regulatory, legal, and trust crisis—not merely a financial-risk issue. My guiding decisions would be: Patient safety comes first.Read the full answer